Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Publication Title
J Immunother Cancer
Document Type
Article
Publication Date
4-1-2020
Keywords
Betacoronavirus; Coronavirus Infections; Drug Approval; Humans; Immunologic Factors; Immunotherapy; Inflammation; Interleukin-6; Neoplasms; Pandemics; Pneumonia, Viral; Receptors, Interleukin-6; 2019-nCoV
Clinical Institute
Cancer
Specialty/Research Institute
Oncology
Specialty/Research Institute
Infectious Diseases
COinS
